Bristol-Myers Squibb
BMY
BMY
2,248 hedge funds and large institutions have $75.7B invested in Bristol-Myers Squibb in 2025 Q2 according to their latest regulatory filings, with 150 funds opening new positions, 804 increasing their positions, 1,014 reducing their positions, and 302 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,248
Holders Change
-196
Holders Change %
-8.02%
% of All Funds
30.13%
Holding in Top 10
16
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-54.29%
% of All Funds
0.21%
New
150
Increased
804
Reduced
1,014
Closed
302
Calls
$1.12B
Puts
$1.26B
Net Calls
-$147M
Net Calls Change
-$173M
Top Buyers
| 1 |
BlackRock
New York
|
+$503M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$472M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$451M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$425M |
| 5 |
Man Group
London,
United Kingdom
|
+$255M |
Top Sellers
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$522M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$417M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$361M |
| 4 |
Bank of New York Mellon
New York
|
-$278M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$250M |